Combination Drug Delivery Approaches in Metastatic Breast Cancer
作者： Jun H. Lee , Anjan Nan
DOI: 10.1155/2012/915375
关键词:
摘要: … Dendrimers are well-established three-dimensional, branched polymers that have been thoroughly investigated as controlled and targeted drug delivery systems. The structure of …
hindawi.com参考文章(111)
Karen L Maughan, Mark A Lutterbie, Peter S Ham, Treatment of breast cancer. American Family Physician. ,vol. 81, pp. 1339- 1346 ,(2010)
Emilio Bria, Diana Giannarelli, Alessandra Felici, William P. Peters, Cecilia Nisticò, Barbara Vanni, Federica Cuppone, Francesco Cognetti, Edmondo Terzoli, Taxanes with anthracyclines as first-line chemotherapy for metastatic breast carcinoma. Cancer. ,vol. 103, pp. 672- 679 ,(2005) , 10.1002/CNCR.20757
Theresa M Allen, Puja Sapra, Internalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs. Cancer Research. ,vol. 62, pp. 7190- 7194 ,(2002)
Paul Geels, Elizabeth Eisenhauer, Andrea Bezjak, Benny Zee, Andrew Day, Palliative Effect of Chemotherapy: Objective Tumor Response Is Associated With Symptom Improvement in Patients With Metastatic Breast Cancer Journal of Clinical Oncology. ,vol. 18, pp. 2395- 2405 ,(2000) , 10.1200/JCO.2000.18.12.2395
Stephen P Ackland, Antonio Anton, George Peter Breitbach, Elena Colajori, Jennifer M Tursi, Carlos Delfino, Anna Efremidis, Adnan Ezzat, Alberto Fittipaldo, Kristo Kolaric, Massimo Lopez, Donatella Viaro, HEPI 013 Study Group, None, Dose-Intensive Epirubicin-Based Chemotherapy Is Superior to an Intensive Intravenous Cyclophosphamide, Methotrexate, and Fluorouracil Regimen in Metastatic Breast Cancer: A Randomized Multinational Study Journal of Clinical Oncology. ,vol. 19, pp. 943- 953 ,(2001) , 10.1200/JCO.2001.19.4.943
Jacek Jassem, Tadeusz Pieńkowski, Anna Płuzańska, Svetislav Jelic, Vera Gorbunova, Zrinka Mrsic-Krmpotic, Juris Berzins, Tomas Nagykalnai, Nelly Wigler, Josette Renard, Stephane Munier, Catherine Weil, Doxorubicin and Paclitaxel Versus Fluorouracil, Doxorubicin, and Cyclophosphamide as First-Line Therapy for Women With Metastatic Breast Cancer: Final Results of a Randomized Phase III Multicenter Trial Journal of Clinical Oncology. ,vol. 19, pp. 1707- 1715 ,(2001) , 10.1200/JCO.2001.19.6.1707
Francesca Greco, María J. Vicent, Siobhan Gee, Arwyn T. Jones, Julia Gee, Robert I. Nicholson, Ruth Duncan, Investigating the mechanism of enhanced cytotoxicity of HPMA copolymer–Dox–AGM in breast cancer cells Journal of Controlled Release. ,vol. 117, pp. 28- 39 ,(2007) , 10.1016/J.JCONREL.2006.10.012
M. Stockler, N.R.C. Wilcken, D. Ghersi, R.John Simes, Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer. Cancer Treatment Reviews. ,vol. 26, pp. 151- 168 ,(2000) , 10.1053/CTRV.1999.0161
Claire Emilienne Soma, Catherine Dubernet, Dvora Bentolila, Simon Benita, Patrick Couvreur, Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles Biomaterials. ,vol. 21, pp. 1- 7 ,(2000) , 10.1016/S0142-9612(99)00125-8
Usha Katragadda, Quincy Teng, Bindhu Madhavi Rayaprolu, Thripthy Chandran, Chalet Tan, Multi-drug delivery to tumor cells via micellar nanocarriers International Journal of Pharmaceutics. ,vol. 419, pp. 281- 286 ,(2011) , 10.1016/J.IJPHARM.2011.07.033